UNK TISSUE EXPANDER
Report
- Report Number
- 9617229-2019-00975
- Event Type
- Injury
- Date Received
- February 14, 2019
- Date of Event
- December 16, 2018
- Report Date
- February 14, 2019
- Manufacturer
- ALLERGAN (COSTA RICA)
- Product Code
- LCJ
- PMA / PMN Number
- K862203
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IT
- Reporter Occupation
- OTHER
Narratives
ARTICLE CITATION: D. CASELLA, G. DI TARANTO AND M. MARCASCIANO ET AL., SUBCUTANEOUS EXPANDERS AND SYNTHETIC MESH FOR BREAST RECONSTRUCTION: LONG-TERM AND PATIENT-REPORTED BREAST-Q OUTCOMES OF A SINGLE-CENTER PROSPECTIVE STUDY, JOURNAL OF PLASTIC, RECONSTRUCTIVE & AESTHETIC SURGERY, HTTPS://DOI.ORG/10.1016/J.BJPS.2018.12.018. THE EVENTS OF NECROSIS, WOUND DEHISCENCE, AND CAPSULAR CONTRACTURE ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. FURTHER INFORMATION REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. THIS IS A KNOWN POTENTIAL ADVERSE EVENT ADDRESSED IN THE PRODUCT LABELING.
JOURNAL ARTICLE TITLED "SUBCUTANEOUS EXPANDERS AND SYNTHETIC MESH FOR BREAST RECONSTRUCTION: LONG-TERM AND PATIENT-REPORTED BREAST-Q OUTCOMES OF A SINGLE-CENTER PROSPECTIVE STUDY" FROM THE 'JOURNAL OF PLASTIC, RECONSTRUCTIVE & AESTHETIC SURGERY PP. 1-8' REPORTS: 16 POST OPERATIVE COMPLICATIONS THAT REQUIRED A SECOND OPERATION OCCURRED AS FOLLOWS: 2 SKIN-NIPPLE NECROSIS, 7 INFECTIONS, 4 WOUND DEHISCENCES, AND 3 SEROMAS, IN ADDITION TO 5 TUMOUR RECURRENCES, 9 CAPSULAR CONTRACTURES, 2 IMPLANT DYSTOPIAS AND 28 CASES OF RIPPLING. THIS RECORD REPRESENTS AN UNSPECIFIED QUANTITY OF DEVICES. THE DEVICES WERE IMPLANTED AS PART OF A RECONSTRUCTION. THE AFFECTED SIDE IS UNKNOWN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 133990 | UNK TISSUE EXPANDER | EXPANDER, SKIN, INFLATABLE | LCJ | ALLERGAN (COSTA RICA) | NI |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |